These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 32702730)
21. Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining. Liu TP; Hsieh YY; Chou CJ; Yang PM R Soc Open Sci; 2018 Nov; 5(11):181321. PubMed ID: 30564416 [TBL] [Abstract][Full Text] [Related]
22. Computational-based drug repurposing methods in COVID-19. Masoudi-Sobhanzadeh Y Bioimpacts; 2020; 10(3):205-206. PubMed ID: 32793443 [TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach. Prabhu NB; Vinay CM; Satyamoorthy K; Rai PS 3 Biotech; 2022 Nov; 12(11):287. PubMed ID: 36164436 [TBL] [Abstract][Full Text] [Related]
24. Corrigendum to "In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19" [Infection, Genetics and Evolution 103 (2022) 105318]. Mirmohammadi SM; Kianmehr A; Sabbaghian A; Mohebbi A; Shahbazmohammadi H; Sheikharabi M; Bazzi Z Infect Genet Evol; 2022 Oct; 104():105361. PubMed ID: 36089457 [No Abstract] [Full Text] [Related]
25. [Modulation of transcriptomic signature of the infected host: a new therapeutic strategy for the management of severe viral infections? Example of the flu]. Poissy J; Terrier O; Lina B; Textoris J; Rosa-Calatrava M Reanimation; 2016; 25(Suppl 2):53-61. PubMed ID: 32288744 [TBL] [Abstract][Full Text] [Related]
26. COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments. Hamed AA; Fandy TE; Tkaczuk KL; Verspoor K; Lee BS Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335943 [TBL] [Abstract][Full Text] [Related]
27. CovMulNet19, Integrating Proteins, Diseases, Drugs, and Symptoms: A Network Medicine Approach to COVID-19. Verstraete N; Jurman G; Bertagnolli G; Ghavasieh A; Pancaldi V; De Domenico M Netw Syst Med; 2020; 3(1):130-141. PubMed ID: 33274348 [No Abstract] [Full Text] [Related]
29. No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19. Rogosnitzky M; Berkowitz E; Jadad AR JMIRx Med; 2020; 1(1):e19583. PubMed ID: 33724265 [TBL] [Abstract][Full Text] [Related]
30. Antidepressant drug treatment protecting from COVID-19: one more piece in the repurposing puzzle. Stingl JC BJPsych Open; 2021 Dec; 8(1):e20. PubMed ID: 34924095 [TBL] [Abstract][Full Text] [Related]
33. CPDR: An R Package of Recommending Personalized Drugs for Cancer Patients by Reversing the Individual's Disease-Related Signature. Chen R; Wang X; Deng X; Chen L; Liu Z; Li D Front Pharmacol; 2022; 13():904909. PubMed ID: 35795573 [TBL] [Abstract][Full Text] [Related]
34. The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience. Gozzo L; Longo L; Vitale DC; Drago F Front Pharmacol; 2020; 11():588132. PubMed ID: 33101042 [No Abstract] [Full Text] [Related]
35. The (Still Unknown) Hypothetical Protective Role of COVID-19 Therapy in Bladder Cancer. Di Gianfrancesco L J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884178 [TBL] [Abstract][Full Text] [Related]
36. A Computational Framework to Characterize the Cancer Drug Induced Effect on Aging Using Transcriptomic Data. Zhao Y; Wang Y; Yang D; Suh K; Zhang M Front Pharmacol; 2022; 13():906429. PubMed ID: 35847024 [TBL] [Abstract][Full Text] [Related]
37. Editorial: Drug Repurposing for COVID-19 Therapy. Maldonado R; Drago F Front Pharmacol; 2021; 12():748886. PubMed ID: 34504433 [No Abstract] [Full Text] [Related]